Author of the publication

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and . Human molecular genetics, 18 (22): 4442–4456 (2009)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk, , , , , , , , , and 252 other author(s). PLoS genetics, 9 (3): e1003212 (2013)Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium, , , , , , , , , and 13 other author(s). Journal of medical genetics, 50 (6): 360–367 (2013)RAD51 135G--C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies, , , , , , , , , and 69 other author(s). American journal of human genetics, 81 (6): 1186–1200 (2007)Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 8 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (35): 5887–5892 (2009)Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2, , , , , , , , , and 172 other author(s). Breast cancer research : BCR, 13 (6): R110 (2011)Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene, , , , , , , , , and 14 other author(s). Nature genetics, 42 (5): 410–414 (2010)Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), , , , , , , , , and 123 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (1): 134–147 (2012)Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 180 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21 (4): 645–657 (2012)Association of death receptor 4 variant (683A C) with ovarian cancer risk in BRCA1 mutation carriers, , , , , , , , , and 6 other author(s). International journal of cancer. Journal international du cancer, 130 (6): 1314–1318 (2012)Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer, , , , , , , , , and 427 other author(s). Nature genetics, 45 (4): 371-84, 384e1-2 (2013)